Drugs Made In America Acquisition Corp Share Price

NASDAQ: DMAA

Small Cap

$10.26

-0.04

(-0.39%)

as on September 16, 2025 at 1:22 am IST

$₹

Drugs Made In America Acquisition Corp Stock Performance

as on September 16, 2025 at 1:22 am IST

Day's Low
Day's High
$10.23
Day's Price Range
$10.27
$10.26
0.29%
Downside
0.10%
Upside
52 Week's Low
52 Week's High
$9.95
52-Week Price Range
$10.3
$10.26
3.02%
Downside
0.39%
Upside

Drugs Made In America Acquisition Corp share price movements today

Previous Close: $10.30
Open: $10.27
Volume: 2.2M
Day's Low - High: $10.23 - $10.27
52 Week Low - High: $9.95 - $10.3

Drugs Made In America Acquisition Corp Historical Returns

1 Month Return: + 0.29 %
3 Month Return: + 1.18 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Drugs Made In America Acquisition Corp Stock Fundamentals & Key Indicators

Check Drugs Made In America Acquisition Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$343.4M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

4903100.00%

Drugs Made In America Acquisition Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Drugs Made In America Acquisition Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Drugs Made In America Acquisition Corp	NA	$343.4M	NA	NA	0.00%
Screaming Eagle Acquisition Corp	NA	$2.1B	NA	NA	0.00%

Drugs Made In America Acquisition Corp Stock's Interest Amongst Investors

Search interest for Drugs Made In America Acquisition Corp Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:20% versus previous 30 day period

Drugs Made In America Acquisition Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Jun 2025
Total Revenue	-	-
Gross Profit	-	-
Operating Income	0	0
EBITDA	0	0
Interest Expense	-	-
Depreciation	-	-
Income Before Tax	1	2
Income Tax Expense	-	-
Net Income	1	2
Net Profit Margin	0.00%	0.00%

Drugs Made In America Acquisition Corp Annual Profit & Loss

All numbers in Millions USD


Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

Drugs Made In America Acquisition Corp Quarterly Cash Flow

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	0	0	1	3
Operating Cash Flow	0	0	0	0
Investing Cash Flow	-	-	-231	-231
Financing Cash Flow	0	0	231	231
Change in Cash	0	0	0	0

Insights on Drugs Made In America Acquisition Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, DMAA stock has moved down by -0.4%

About Drugs Made In America Acquisition Corp

Drugs Made In America Acquisition Corp. is a blank check company. The Company is incorporated as an exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus its search for business combination targets in the pharmaceutical industry.

Organisation	Drugs Made In America Acquisition Corp
Headquarters	1 East Broward Boulevard, Fort Lauderdale, FL, United States, 33301
CEO	Ms. Lynn Stockwell
E-voting on shares	Click here to vote

Key Management of Drugs Made In America Acquisition Corp

Name	Title
Ms. Lynn Stockwell	CEO & Executive Chairman
Mr. Glenn Charles Worman	Chief Financial Officer

FAQs

What is Drugs Made In America Acquisition Corp share price today?

Drugs Made In America Acquisition Corp share price today is $10.26 as on September 16, 2025 at 1:22 am IST at the close of the market. Drugs Made In America Acquisition Corp share today touched a day high of $10.27 and a low of $10.23.

What is the 52 week high and 52 week low for Drugs Made In America Acquisition Corp share?

Drugs Made In America Acquisition Corp share touched a 52 week high of $10.3 on September 12, 2025 and a 52 week low of $9.95 on February 25, 2025. Drugs Made In America Acquisition Corp stock price today i.e. September 16, 2025 at 1:22 am IST is closed at $10.26,which is 0.39% down from its 52 week high and 3.12% up from its 52 week low.

What is Drugs Made In America Acquisition Corp's market capitalisation today?

Drugs Made In America Acquisition Corp market capitalisation is $0.00T as on September 16, 2025 at 1:22 am IST.

How to invest in Drugs Made In America Acquisition Corp Stock (DMAA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Drugs Made In America Acquisition Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Drugs Made In America Acquisition Corp Shares that will get you 0.1462 shares as per Drugs Made In America Acquisition Corp share price of $10.26 per share as on September 16, 2025 at 1:22 am IST.

What is the minimum amount required to buy Drugs Made In America Acquisition Corp Stock (DMAA) from India?

Indian investors can start investing in Drugs Made In America Acquisition Corp (DMAA) shares with as little as ₹88.042 or $1 (as of September 16, 2025 at 6:43 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Drugs Made In America Acquisition Corp stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 6:43 pm IST). Based on Drugs Made In America Acquisition Corp share’s latest price of $10.26 as on September 16, 2025 at 1:22 am IST, you will get 0.9747 shares of Drugs Made In America Acquisition Corp. Learn more about fractional shares .